# RIFAXIMIN
> **ANDA213713** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2025-05-29
## Drug
- **FDA Application Number:** ANDA213713
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAXIMIN
- **Generic name:** Rifaximin
- **Active ingredients:** RIFAXIMIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ INC
- **First approval:** 2025-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213713)
---
*AI Analytics · CC0 1.0*